FDA offers Pfizer priority review for tafamidis; Clarivate to merge with Churchill Capital
→ The FDA is giving Pfizer’s tafamidis a quick look over in advance of a likely approval. The agency will give the drug a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
